Ertapenem (MK-0826), a new carbapenem: Comparative in vitro activity against clinically significant anaerobes
- 31 October 2002
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 44 (2) , 181-186
- https://doi.org/10.1016/s0732-8893(02)00430-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group StrainsAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical CentersAntimicrobial Agents and Chemotherapy, 2001
- Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas , and Peptostreptococcus SpeciesAntimicrobial Agents and Chemotherapy, 2001
- Comparative In Vitro Activities of Ertapenem (MK-0826) against 1,001 Anaerobes Isolated from Human Intra-Abdominal InfectionsAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational TrialClinical Infectious Diseases, 2000
- In Vitro Activities of the Potent, Broad-Spectrum Carbapenem MK-0826 (L-749,345) against Broad-Spectrum β-Lactamase-and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli Clinical IsolatesAntimicrobial Agents and Chemotherapy, 1999
- In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc testsJournal of Antimicrobial Chemotherapy, 1999
- In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)Antimicrobial Agents and Chemotherapy, 1998
- A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United StatesDiagnostic Microbiology and Infectious Disease, 1994
- Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodologyAntimicrobial Agents and Chemotherapy, 1990